# A Study in Asymptomatic HIV Infected Patients to Investigate Pharmacodynamics, Pharmacokinetics, Safety and Toleration of UK-453,061

> **NCT00348673** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 49 (actual)

## Conditions studied

- HIV-1

## Interventions

- **DRUG:** UK-453,061
- **DRUG:** UK-453,061

## Key facts

- **NCT ID:** NCT00348673
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2007-02
- **Final completion:** 2007-02
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2013-10-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00348673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00348673, "A Study in Asymptomatic HIV Infected Patients to Investigate Pharmacodynamics, Pharmacokinetics, Safety and Toleration of UK-453,061". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00348673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*